Other OTC Pharmaceuticals - Cuba

  • Cuba
  • In 2024, the revenue in the Other OTC Pharmaceuticals market in Cuba amounts to US$293.80m.
  • It is projected that the market will experience an annual growth rate of 0.85% (CAGR 2024-2029).
  • When compared to the global market, the in the United States generates the highest revenue, reaching US$7,171.00m in 2024.
  • Taking into account the total population figures, per person revenues amount to US$26.29 in 2024.
  • The Cuban market for Other OTC Pharmaceuticals is experiencing a surge in demand for traditional herbal remedies and natural remedies.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Cuba is experiencing steady growth due to increasing customer preferences for self-medication, rising healthcare awareness, and a favorable regulatory environment.

Customer preferences:
Customers in Cuba are increasingly opting for over-the-counter (OTC) pharmaceutical products for self-medication. This preference is driven by the convenience, accessibility, and affordability of OTC medicines. With a growing awareness of healthcare and a desire for self-care, consumers are more inclined to purchase OTC products for common ailments and minor health issues. This trend is further supported by the availability of a wide range of OTC pharmaceuticals in local pharmacies and retail outlets.

Trends in the market:
The Other OTC Pharmaceuticals market in Cuba is witnessing several key trends. Firstly, there is a growing demand for OTC analgesics, such as pain relievers and fever reducers, as consumers seek immediate relief from common ailments. Additionally, there is a rising demand for OTC cough and cold medicines, as well as gastrointestinal remedies, reflecting the prevalence of respiratory and digestive health issues in the population. Furthermore, the market is experiencing an increased demand for OTC dermatological products, including creams, ointments, and lotions, as consumers prioritize skincare and address common skin conditions. These trends indicate a shift towards self-care and the increasing reliance on OTC pharmaceuticals for minor health concerns.

Local special circumstances:
Cuba's healthcare system is characterized by universal access to healthcare services, including pharmaceuticals. The government plays a significant role in regulating and providing healthcare services, including the distribution of OTC pharmaceuticals. The local special circumstance in Cuba is the presence of a well-established network of pharmacies and retail outlets that offer a wide range of OTC products. This accessibility encourages consumers to purchase OTC pharmaceuticals for self-medication, contributing to the growth of the market.

Underlying macroeconomic factors:
The growth of the Other OTC Pharmaceuticals market in Cuba is also influenced by underlying macroeconomic factors. The country's improving economic conditions and rising disposable incomes have resulted in increased consumer spending on healthcare products, including OTC pharmaceuticals. Additionally, the government's efforts to promote self-care and reduce the burden on the healthcare system have created a favorable regulatory environment for OTC medicines. The availability of affordable OTC products, coupled with the ease of accessibility, has further fueled the market growth. In conclusion, the Other OTC Pharmaceuticals market in Cuba is witnessing steady growth driven by customer preferences for self-medication, increasing healthcare awareness, and a favorable regulatory environment. The market trends indicate a shift towards self-care and the growing reliance on OTC pharmaceuticals for minor health concerns. With a well-established network of pharmacies and retail outlets, coupled with improving economic conditions and government support, the market is expected to continue its positive trajectory in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)